$6.77
0.182.73%
Last update: Oct 15, 4:00 PM
$6.30
-0.29-4.4%
Eupraxia Pharmaceuticals Inc
EPRXNASDAQ
Eupraxia Pharmaceuticals (EPRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.20 | $-0.16 | $-0.21 |
| Actual | $-0.23 | $-0.23 | $-0.37 | $-0.19 |
| Surprise | 0.00% | -15.0% | -131.3% | +9.52% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.26 | $-0.28 | $-0.24 | $-0.25 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.23 | $-0.23 | 0.00 % |
| Q1 | May 12, 2026 | $-0.23 | $-0.20 | -15.0 % |
| Q4 | Mar 12, 2026 | $-0.37 | $-0.16 | -131.3 % |
| Q3 | Nov 4, 2025 | $-0.19 | $-0.21 | 9.52 % |
